Singapur #9107 (v.1)
Datos básicos
- Notificada en
-
G/MA/QR/N/SGP/6 06/11/2024
- Validez de la versión
-
11/04/2023 -
01/09/2024
Versión anterior v.1
- Miembro informante
- Singapur
- En vigor desde
- Fecha de supresión
- En vigor
- Descripción general
-
Non-automatic licence for the import of Chinese proprietary medicines (CPMs)
- Fundamento jurídico nacional
-
Medicines Act, 1975
- Mecanismo administrativo
-
While the controls of chemical and biologic drugs have been transferred from the Medicines Act to the Health Products Act from 1 Nov 2016, CPMs will continue to be regulated under the Medicines Act for now.
More information can be found at: https://www.hsa.gov.sg/.
Administered by HSA.
- Entidades responsables
-
- Versión del SA
-
HS 2022
- Signatura de la OMC a que se hace referencia
Metadatos
- Justificaciones en el marco de la OMC
-
XX:(b) - (b) necessary to protect human, animal or plant life or health;
GATT 1994 (GATT 1947 provisions)
Notificada como: Article XX(b) of the GATT - Compromisos Internacionales (distintos de los asumidos en el marco de la OMC)
-
- Interlocutores afectados
- Interlocutores no afectados
Medidas
- Restricciones notificadas
- NAL
| Signatura |
|---|
|
NAL
|
Líneas arancelarias
|
12
|
Chapter 12
|
Chinese proprietary medicines (CPMs) refer to medicinal products, used according to the traditional...
|
|
|
13
|
Chapter 13
|
Chinese proprietary medicines (CPMs) refer to medicinal products, used according to the traditional...
|
|
|
30
|
Chapter 30
|
Chinese proprietary medicines (CPMs) refer to medicinal products, used according to the traditional...
|
|